Vera Therapeutics Inc. (VERA)
30.26
-0.94 (3.01%)
Upcoming Events
Latest Headlines
Vera Therapeutics ORIGIN 3 trial meets all endpoints for IgAN drug
October 22, 2026 10:09 AM - StreetInsider
Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of M
October 22, 2026 10:05 AM - StreetInsider
Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast
October 20, 2026 8:00 AM - StreetInsider
Leerink Starts Vera Therapeutics (VERA) at Market Perform
October 12, 2026 6:27 AM - StreetInsider
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026 4:05 PM - StreetInsider
Vera Therapeutics to present ORIGIN 3 trial data at ASN Kidney Week
October 2, 2026 9:25 AM - StreetInsider
Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN
October 2, 2026 9:24 AM - Globe NewsWire
Form 4 Vera Therapeutics, Inc. For: Sep 15 Filed by: Fordyce Marshall
September 17, 2026 4:29 PM - SEC Filing
TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)
September 15, 2026 10:46 AM - StreetInsider
Raymond James Reiterates Strong Buy Rating on Vera Therapeutics (VERA)
September 15, 2026 9:58 AM - StreetInsider
Form 8-K Vera Therapeutics, Inc. For: Sep 15
September 15, 2026 6:46 AM - SEC Filing
Vera Therapeutics drug meets all endpoints in two-year IgAN trial
September 15, 2026 6:30 AM - StreetInsider
Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
September 15, 2026 6:30 AM - StreetInsider
Form 4 Vera Therapeutics, Inc. For: Sep 11 Filed by: Young Joseph R
September 14, 2026 4:28 PM - SEC Filing
Vera Therapeutics (VERA) PT Raised to $83 at JPMorgan
September 8, 2026 8:48 AM - StreetInsider
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 4, 2026 4:05 PM - StreetInsider
Vera Therapeutics to Participate at Upcoming Investor Conferences
September 1, 2026 7:30 AM - StreetInsider
Increasing unusual call volume: DKS CCCC IMPP VERA EMBJ GMAB DUST BCS KHC SOLZ SN ANF AI PLAB
August 26, 2026 10:40 AM - StreetInsider
Increasing unusual option volume: DKS VERA CRON BBWI AS ARDX VSTM ENR MAIN EWZ XE
August 26, 2026 3:11 AM - StreetInsider
Vera Therapeutics Inc. (VERA) spreader of 6430 contracts of September 35 and 45 calls, share price up 3.1%
August 25, 2026 3:23 PM - StreetInsider
Form SCHEDULE 13G/A Vera Therapeutics, Inc. Filed by: Kynam Capital Management, LP
August 14, 2026 12:16 PM - SEC Filing
Form 4/A Vera Therapeutics, Inc. For: Jul 07 Filed by: Fordyce Marshall
August 12, 2026 6:43 PM - SEC Filing
Form 4/A Vera Therapeutics, Inc. For: Jun 23 Filed by: Fordyce Marshall
August 12, 2026 6:42 PM - SEC Filing
Form 4/A Vera Therapeutics, Inc. For: May 12 Filed by: Fordyce Marshall
August 12, 2026 6:39 PM - SEC Filing
Vera Therapeutics (VERA) PT Lowered to $80 at Goldman Sachs
August 12, 2026 4:29 PM - StreetInsider
Vera Therapeutics (VERA) PT Lowered to $90 at H.C. Wainwright
August 12, 2026 7:21 AM - StreetInsider
Vera Therapeutics, Inc. (VERA) Tops Q2 EPS by 13c
August 10, 2026 5:22 PM - StreetInsider
Form 10-Q Vera Therapeutics, Inc. For: Jun 30
August 10, 2026 4:12 PM - SEC Filing
Form 8-K Vera Therapeutics, Inc. For: Aug 10
August 10, 2026 4:06 PM - SEC Filing
Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 10, 2026 4:05 PM - StreetInsider
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G Vera Therapeutics, Inc. Filed by: STATE STREET CORP
August 7, 2026 11:11 AM - SEC Filing
Form 4 Vera Therapeutics, Inc. For: Aug 03 Filed by: Boman Nancy Lee
August 5, 2026 4:18 PM - SEC Filing
Form 3 Vera Therapeutics, Inc. For: Aug 03 Filed by: Boman Nancy Lee
August 5, 2026 4:17 PM - SEC Filing
Form SCHEDULE 13G/A Vera Therapeutics, Inc. Filed by: BlackRock, Inc.
July 30, 2026 11:19 AM - SEC Filing
Full Article List
